Synopsis
From the editors of the Neurology Journal, Neurology Minute is a daily 1-2 minute brief podcast delivering a quick, practical rundown of what you need to know in neurology. Neurology Minute is hosted by Dr. Stacey Clardy, with contributions by leading neurologists and neuroscientists.
Episodes
-
When Myoclonus is Reversible
02/08/2023 Duration: 03minDr. Kathryn Zuchowski discusses her NeuroByte, "When Myoclonus Is Reversible". Show references: https://learning.aan.com/diweb/catalog/item?id=11546015 This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
-
2024 Medicare Physician Fee Schedule Proposed Rule
01/08/2023 Duration: 05minMatt Kershner, Director, of Regulatory Affairs & Policy, at the American Academy of Neurology, discusses the 2024 Medicare Physician Fee Schedule Proposed Rule. Show references: https://www.aan.com/advocacy/capitol-hill-report This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
-
Pediatric Epilepsy Surgery
31/07/2023 Duration: 03minDr. Adam Hartman discusses pediatric epilepsy surgery. Show references: https://www.thelancet.com/pdfs/journals/lanchi/PIIS2352-4642(23)00082-2.pdf https://pubmed.ncbi.nlm.nih.gov/37212692/ This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
-
Elamipretide for Mytochondrial Myopathy
28/07/2023 Duration: 02minDr. Amel Karaa discusses the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies. Show references: https://n.neurology.org/content/101/3/e238
-
Sarepta Announces FDA Approval of ELEVIDYS
27/07/2023 Duration: 01minDr. Hoda Abdel-Hamid discusses the recent FDA approval for the first-ever gene therapy for Duchenne muscular dystrophy.
-
Anti-Seizure Medication
26/07/2023 Duration: 03minDr. Irfan Sheikh sheds light on the usage of anti-seizure medications within the inpatient setting.
-
Cognitive Decline Following Heart Attack
25/07/2023 Duration: 02minDr. Rae Bacharach discusses the Neurology Today article, "Cognitive Decline Appears to Speed Up in the Years Following a Heart Attack". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/07060/cognitive_decline_appears_to_speed_up_in_the_years.8.aspx
-
Traumatic Brain Injury in Children
24/07/2023 Duration: 03minDr. Halley Alexander discusses the paper, "It's Been a TRACK-TBI LONG Time Coming, but Well Worth the Wait". Show references: https://n.neurology.org/content/early/2023/06/21/WNL.0000000000207682
-
New Treatment for IDH Mutant Gliomas
21/07/2023 Duration: 01minDr. Ingo K. Mellinghoff discusses his paper, "Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma". Show references: https://pubmed.ncbi.nlm.nih.gov/37272516/
-
Patient-Assistance Programs, Kickbacks, and the Courts
20/07/2023 Duration: 03minDr. Jacob T. Elberg discusses his paper, "Patient-Assistance Programs, Kickbacks, and the Courts". Show references: https://www.nejm.org/doi/full/10.1056/NEJMp2303535
-
Neurologic Complications of Cardiac and Pulmonary Disease: Part 3
19/07/2023 Duration: 02minIn Part 3 of a 3-part series, Shraddha Mainali, MD, discusses her article, "Neurologic Complications of Cardiac and Pulmonary Disease" from the June Continuum Neurology of Systemic Disease issue. This article and accompanying Continuum Audio interview are available to subscribers at continpub.com/NeuroCardiacDisease.
-
Neurologic Complications of Cardiac and Pulmonary Disease: Part 2
18/07/2023 Duration: 03minIn Part 2 of a 3-part series, Shraddha Mainali, MD, discusses her article, "Neurologic Complications of Cardiac and Pulmonary Disease" from the June Continuum Neurology of Systemic Disease issue. This article and accompanying Continuum Audio interview are available to subscribers at continpub.com/NeuroCardiacDisease.
-
Neurologic Complications of Cardiac and Pulmonary Disease: Part 1
17/07/2023 Duration: 04minIn Part 1 of a 3-part series, Shraddha Mainali, MD, discusses her article, "Neurologic Complications of Cardiac and Pulmonary Disease" from the June Continuum Neurology of Systemic Disease issue. This article and accompanying Continuum Audio interview are available to subscribers at continpub.com/NeuroCardiacDisease.
-
Dual Antiplatelet Therapy vs Alteplase for Patients With Acute Ischemic Stroke
14/07/2023 Duration: 03minDr. Thanh Nguyen discusses his paper, "Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke". Show references: https://jamanetwork.com/journals/jama/article-abstract/2806532 This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
-
Clinico-radiologic and Pathological Evaluation of Corticobasal Syndrome
14/07/2023 Duration: 03minDr. Jonathan Graff-Radford about everything we need to know about corticobasal syndrome. Show references: https://n.neurology.org/content/100/17_Supplement_2/1581 This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
-
Interstate Medical Licensure Compact
12/07/2023 Duration: 03minDr. Eric Anderson discusses the interstate medical licensure compact. Show references: https://www.aan.com/practice/telehealth-advocacy This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
-
Traumatic Encephalopathy Syndrome
11/07/2023 Duration: 03minDr. Halley Alexander discusses the paper, "Traumatic Encephalopathy Syndrome: Can It Stand the Test of Time?" Show references: https://n.neurology.org/content/early/2023/06/28/WNL.0000000000207711 This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
-
Migraine and Sleep
10/07/2023 Duration: 03minDr. Andrew Charles discusses new updates related to migraine and sleep. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
-
Simulation-Based Planning of ALS Trials
07/07/2023 Duration: 02minDrs. Ruben P.A. van Eijk and Jordi van Unnik discuss the planning of interim analyses for clinical trials in ALS to maximize patient safety and minimize exposure to ineffective or harmful drugs. Show references: https://n.neurology.org/content/100/23/e2398
-
CSF Findings Across GBS
06/07/2023 Duration: 01minDr. Bart Jacobs discusses cerebrospinal fluid findings in relation to clinical and electrodiagnostic subtypes, severity, and outcome of Guillain-Barré syndrome. Show references: https://n.neurology.org/content/100/23/e2386